Description: Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Home Page: www.vetoquinol.com
Magny-Vernois
Lure,
70204
France
Phone:
33 3 84 62 55 55
Officers
| Name | Title |
|---|---|
| Mr. Alain Masson | Deputy CEO & Pharmacist Manager |
| Mr. Matthieu Frechin | CEO & Non-Independent Chairman of the Board |
| Mr. Regis Vimal du Monteil | Chief Financial Officer |
| Mr. Dominique Derveaux | Chief Operations Officer |
| Philippe Gruet | Chief Scientific Officer |
| Sandrine Perrier | Chief Information Officer |
| Laurent Thore | Director of Partnerships, Legal Affairs & Risks |
| Xavier Berthet | Director of Group Communications |
| Ms. Isabelle Proust-Cabrera | Group Director of Human Resources |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 19.3734 |
| Price-to-Book MRQ: | 1.6843 |
| Price-to-Sales TTM: | 1.726 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2519 |